GMJ

Prof. Giorgi Pkhakadze, MD, MPH, PhD

MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
Follow:
1661 Articles

Trump’s Perfect Cognitive Test Score: What Montreal Cognitive Assessment Really Measures

President Trump's perfect 30/30 score on cognitive testing prompts medical experts to clarify what the Montreal Cognitive Assessment actually measures.…

Breakthrough Drug Targeting ‘Undruggable’ KRAS Mutation Nearly Doubles Pancreatic Cancer Survival

New targeted therapy daraxonrasib successfully inhibits KRAS mutations in pancreatic cancer, nearly doubling survival times. Clinical trial shows 60% reduction…

Large Brazilian Study Links Table Salt Habits to Cognitive Decline in 8,300 Older Adults

A comprehensive study of 8,300 older Brazilian adults found that men are significantly more likely to add salt at the…

Prenatal Zika exposure linked to vision, hearing deficits despite apparently healthy births

New research reveals that infants with prenatal Zika exposure develop vision, hearing, and social deficits by 12 months despite appearing…

Insulin Remains Inaccessible to Millions Despite Century of Progress

More than a century after its discovery, insulin remains inaccessible to millions despite being a WHO essential medicine. Access barriers…

Eswatini Targets Malaria Elimination by 2028 as WHO Reports 2.3 Billion Cases Averted Since 2000

Eswatini targets malaria elimination by 2028 as WHO reports 2.3 billion cases averted globally since 2000. The country has reduced…

UK Health Regulator Issues Class 4 Alert for Denosumab Injection Labelling Error

MHRA issues Class 4 alert for Ponlimsi denosumab after Teva UK reports carton labelling error stating "For application to the…

MHRA Reports Progress on Health Equity Through Regulatory Reform

The UK's MHRA has published its 2025-2026 Public Sector Equality Duty report, demonstrating systematic progress in embedding equality principles across…

© 2026 GMJ News · PHIG · Sheni Network